Pretreatment serum markers and lymphocyte response to interleukin-2 therapy

Lymphocytosis is a marker of subcutaneous interleukin (IL)-2 therapy efficacy, whereas baseline elevated inflammatory indices were noticed in IL-2-resistant disease. The aim of this study was to analyse the relationship between pretreatment circulating values of IL-6, neopterin, sIL-2R, ESR and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fumagalli, L, Lissoni, P, Felice, G Di, Meregalli, S, Valsuani, G, Mengo, S, Rovelli, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362330/
https://www.ncbi.nlm.nih.gov/pubmed/10408846
http://dx.doi.org/10.1038/sj.bjc.6690371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362330/
https://www.ncbi.nlm.nih.gov/pubmed/10408846
http://dx.doi.org/10.1038/sj.bjc.6690371

Ejemplares similares